The global epidemic of hypertension is largely uncontrolled and hypertension remains the
leading cause of noncommunicable disease deaths worldwide. Suboptimal adherence …

Suboptimal adherence to antihypertensive medication is a major contributor to poor blood
pressure control. Several methods, direct or indirect, are available for measuring adherence …

We hypothesized that screening for nonadherence to antihypertensive treatment using liquid
chromatography-tandem mass spectrometry–based biochemical analysis of urine/serum …

298 Hypertension August 2016 drug adherence. Assessment of adherence is not part of
routine clinical practice and is seldom performed in studies, even those testing drugs or …

Adherence to treatment is now well recognized as a crucial key in the effectiveness of
antihypertensive drugs; however, it is often overlooked in the management of hypertension …

It has been postulated that catheter-based renal denervation (RDN) may lower blood
pressure (BP) and improve severity of obstructive sleep apnea (OSA) in resistant …

Proceedings from the 2nd European Clinical Consensus Conference for device-based
therapies for hypertension: state of the art and considerations for the future | European Heart …

Hypertension is the most common chronic disease and the leading risk factor for disability
and premature deaths in the world, accounting for more than 9 million deaths annually …

This paper reviews high-resolution mass spectrometry (HRMS) approaches using time-of-
flight or Orbitrap techniques for research and application in various toxicology fields …

The quality of assessment of non-adherence to treatment in hypertensive is poor. Within this
review, we discuss the different methods used to assess adherence to blood-pressure …